Please login to the form below

Not currently logged in
Email:
Password:

Pharmexx get CQC accreditation

Pharmexx is the first UK CSO to be awarded accreditation by the CQC for its health management services business unit

Pharmexx is the first UK contract sales organisation (CSO) to be awarded accreditation by the Care Quality Commission (CQC) for its health management services business unit, which provides services to pharma and the NHS in the UK.

The review by the CQC certified that Pharmexx met the necessary level of safeguarding patient welfare and monitoring quality of service provision. The contract sales organisation also demonstrated that it has sufficient amounts of staffing with the right competencies, skills and experience to meet the needs of its clients.

Pharmexx is Europe's largest (CSO). Its health management service business unit was set up in early 2010.

Nigel Mansford, MD of Pharmexx, UK said: "In early 2010, we recognised a requirement to invest in the development of our healthcare managed service business. The pace of this investment was driven by the significant change to the UK market place and the feedback from our pharma and NHS customers to offer high-quality services that they were unable to find via other providers."

He continued: "The appointment of a high-quality and experienced team was the first step in the long pathway to becoming the first CSO to be CQC accredited. This is a tremendous and exciting time for our clients and for everyone involved with Pharmexx."

The CQC is the independent accreditation body of health and social care in England. It regulates the care provided by private healthcare companies as well as the NHS, local authorities and voluntary organisations.

11th January 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics